| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.32 | 3e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 2e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 7e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |